The Centers for Medicare & Medicaid Services (CMS) recently published its Proposed 2026 Physician Fee Schedule Rule (Proposed Rule), with extensive implications for drug pricing, Average Sales Price ...
In December, the Centers for Medicare and Medicaid Services released justifications for the maximum fair prices it arrived in negotiations with drug makers for the first 10 medications selected. When ...
Every July, the Centers for Medicare & Medicaid Services (CMS) publishes two proposed rules relating to how it plans to administer the Medicare Part B program for the next calendar year: the physician ...
The drug pricing paradigms of Canada, France, and Germany offer lessons for the United States on how to arrive at a “fair price” for drugs in a predictable and transparent manner. Yet translating a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results